{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:51:39Z","timestamp":1773737499016,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s395577","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:10:05Z","timestamp":1671757805000},"page":"4303-4313","source":"Crossref","is-referenced-by-count":19,"title":["Brolucizumab in Neovascular Age-Related Macular Degeneration \u2013 Indian Real-World Experience: The BRAILLE Study \u2013 Fifty-Two-Week Outcomes"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9693-7882","authenticated-orcid":true,"given":"Debdulal","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniruddha","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-7759","authenticated-orcid":true,"given":"Jay U","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumen","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhendu","family":"Boral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnendu","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar Kanti","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnab","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/OPTH.S33372","volume":"6","author":"Stewart","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","volume":"105","author":"Thomas","year":"2021","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms22031170","volume":"22","author":"Pugazhendhi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12913-022-07972-w","volume":"22","author":"Ferrante","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.2147\/OPTH.S328160","volume":"15","author":"Chakraborty","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ophtha.2020.06.028","volume":"128","author":"Dugel","year":"2021","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preteyeres.2017.12.002","volume":"65","author":"Mehta","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40123-021-00345-2","volume":"10","author":"Chakraborty","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"ref9","unstructured":"European Medicines Agency. ICH topic E 2 A clinical safety data management: definitions and standards for expedited reporting; 1995. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-15.pdf. Accessed October 9, 2022."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1097\/IAE.0000000000001753","volume":"38","author":"Qin","year":"2018","journal-title":"Retina"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2147\/OPTH.S269596","volume":"15","author":"Groppe","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/jcm10132758","volume":"10","author":"Bilgic","year":"2021","journal-title":"J Clin Med"},{"key":"ref14","unstructured":"Walter SD, Saba NJ Efficacy and durability of brolucizumab in patients being transitioned from prior anti-VEGF therapy. Presented at the ASRS 39th Annual Scientific Meeting; San Antonio (Texas); 2021."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamaophthalmol.2020.7085","volume":"139","author":"Enr\u00edquez","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/bjophthalmol-2020-318672","volume":"106","author":"Bulirsch","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41433-020-1111-x","volume":"35","author":"Sharma","year":"2021","journal-title":"Eye"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1007\/s12325-022-02193-3","volume":"39","author":"Finger","year":"2022","journal-title":"Adv Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"101197","DOI":"10.1016\/j.ajoc.2021.101197","volume":"24","author":"Chakraborty","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ophtha.2017.07.005","volume":"125","author":"Daien","year":"2018","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/IAE.0000000000000801","volume":"36","author":"Williams","year":"2016","journal-title":"Retina"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/jamaophthalmol.2021.4585","volume":"140","author":"Khanani","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.ophtha.2020.11.011","volume":"128","author":"Mon\u00e9s","year":"2021","journal-title":"Ophthalmology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.oret.2021.05.003","volume":"6","author":"Singer","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajo.2016.06.019","volume":"169","author":"Esen","year":"2016","journal-title":"Am J Ophthalmol"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=86399","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=86399","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:10:12Z","timestamp":1671757812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/brolucizumab-in-neovascular-age-related-macular-degeneration--indian-2-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2147\/opth.s395577","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}